Clinical Trial Update: A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis [NA]

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating Episil Oral Liquid for chemotherapy- and/or radiation-induced oral mucositis in cancer patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Episil

Snippet

Sponsor: Solasia Pharma K.K. | Conditions: Chemotherapy- and/or Radiation-induced Oral Mucositis | NA | Status: COMPLETED